Table 1. ESKAPE isolates, 2009 - 2010 and 2012 - 2014.
| ESKAPE | Medicine | Surgery | ICU | Overall | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2009 - 2010 (2,227) | 2012 - 2014 (3,271) | P | 2009 - 2010 (887) | 2012 - 2014 (1,860) | P | 2009 - 2010 (663) | 2012 - 2014 (1,010) | P | 2009 - 2010 (3,777) | 2012 - 2014 (6,141) | P | |
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |||||
| Enterococcus faecium | 119 (5.3) | 153 (4.7) | 0.3101 | 40 (4.5) | 71 (3.8) | 0.4075 | 35 (5.3) | 31 (3.1) | 0.0289 | 194 (5.1) | 255 (4.1) | 0.0251 |
| Staphylococcus aureus | 193 (8.7) | 214 (6.5) | 0.0039 | 104 (11.7) | 117 (6.3) | <0.0001 | 99 (14.9) | 101 (10.0) | <0.0001 | 396 (10.5) | 432 (7.0) | <0.0001 |
| Klebsiella pneumoniae | 301 (13.5) | 448 (13.7) | 0.8728 | 114 (12.8) | 239 (12.8) | 0.8557 | 82 (12.4) | 129 (12.8) | 0.8218 | 497 (13.2) | 816 (13.3) | 0.8788 |
| Acinetobacter baumannii | 100 (4.5) | 147 (4.5) | 1.000 | 33 (3.7) | 95 (5.0) | 0.1212 | 56 (8.4) | 173 (17.1) | <0.0001 | 189 (5.0) | 415 (6.7) | 0.0004 |
| Pseudomonas aeruginosa | 271 (12.2) | 357 (10.9) | 0.0038 | 106 (11.9) | 201 (10.8) | 0.3999 | 112 (16.9) | 152 (15.0) | 0.3372 | 489 (12.9) | 710 (11.6) | 0.0423 |
| Enterobacter | 92 (4.1) | 118 (3.6) | 0.3515 | 31 (3.5) | 69 (3.7) | 0.8281 | 29 (4.4) | 33 (3.3) | 0.2300 | 152 (4) | 220 (3.6) | 0.2764 |
| ESKAPE | 1,076 (48.3) | 1,437 (43.9) | 0.0014 | 428 (48.2) | 792 (42.6) | <0.0001 | 413 (62.3) | 619 (61.3) | 0.6813 | 1,917 (50.8) | 2,848 (46.4) | <0.0001 |
| PM+S/I | <0.0001 | <0.0001 | ||||||||||
ESKAPE, Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.; ICU, intensive care unit; M, medicine; S, surgery; I, intensive care unit.